---
figid: PMC7698403__cells-09-02494-g001
figlink: pmc/articles/PMC7698403/figure/cells-09-02494-f001/
number: F1
caption: Clinical pathway to metastatic castration resistant prostate cancer (mCRPC)
  with the current treatment options.
pmcid: PMC7698403
papertitle: Clinical Actionability of the Genomic Landscape of Metastatic Castration
  Resistant Prostate Cancer.
reftext: Wout Devlies, et al. Cells. 2020 Nov;9(11):2494.
pmc_ranked_result_index: '27463'
pathway_score: 0.7509046
filename: cells-09-02494-g001.jpg
figtitle: Clinical pathway to metastatic castration resistant prostate cancer (mCRPC)
  with the current treatment options
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7698403__cells-09-02494-g001.html
  '@type': Dataset
  description: Clinical pathway to metastatic castration resistant prostate cancer
    (mCRPC) with the current treatment options.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GNRH1
  - enzalutamide
  - abiraterone
  - docetaxel
  - Abiraterone
  - cabazitaxel
  - Prostate Cancer
genes:
- word: LHRH
  symbol: LHRH
  source: hgnc_prev_symbol
  hgnc_symbol: GNRH1
  entrez: '2796'
chemicals:
- word: enzalutamide
  source: MESH
  identifier: C540278
- word: abiraterone
  source: MESH
  identifier: C089740
- word: docetaxel
  source: MESH
  identifier: C067311
- word: Abiraterone
  source: MESH
  identifier: C089740
- word: cabazitaxel
  source: MESH
  identifier: C552428
diseases:
- word: Prostate Cancer
  source: MESH
  identifier: D011471
figid_alias: PMC7698403__F1
redirect_from: /figures/PMC7698403__F1
figtype: Figure
---
